JP2011505341A - 炎症性、心血管およびcns障害を治療するビアリールpde4抑制剤 - Google Patents
炎症性、心血管およびcns障害を治療するビアリールpde4抑制剤 Download PDFInfo
- Publication number
- JP2011505341A JP2011505341A JP2010535064A JP2010535064A JP2011505341A JP 2011505341 A JP2011505341 A JP 2011505341A JP 2010535064 A JP2010535064 A JP 2010535064A JP 2010535064 A JP2010535064 A JP 2010535064A JP 2011505341 A JP2011505341 A JP 2011505341A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- mmol
- nhc
- compound
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC12C(Nc(c(*)c3)c(*)c(C4CCCCCCC4)c3O*)=C1CCCCCC2 Chemical compound CC12C(Nc(c(*)c3)c(*)c(C4CCCCCCC4)c3O*)=C1CCCCCC2 0.000 description 31
- CQJZIRBMSWOCME-UHFFFAOYSA-N COc(ccc(CBr)c1)c1-c1cc(NO)ccc1 Chemical compound COc(ccc(CBr)c1)c1-c1cc(NO)ccc1 CQJZIRBMSWOCME-UHFFFAOYSA-N 0.000 description 4
- GJPMJCKAEPPFSN-UHFFFAOYSA-N BCc(cc1)cc(B)c1OC Chemical compound BCc(cc1)cc(B)c1OC GJPMJCKAEPPFSN-UHFFFAOYSA-N 0.000 description 1
- XYZWJCWBNQYJMM-FXLUECPISA-N C/C=C(\C=C(/C)\Cl)/c(c(F)c(CBr)cc1)c1OC Chemical compound C/C=C(\C=C(/C)\Cl)/c(c(F)c(CBr)cc1)c1OC XYZWJCWBNQYJMM-FXLUECPISA-N 0.000 description 1
- CJIRWMAWYOWROD-DUXPYHPUSA-N C/C=C/c1cc(Cl)ccc1 Chemical compound C/C=C/c1cc(Cl)ccc1 CJIRWMAWYOWROD-DUXPYHPUSA-N 0.000 description 1
- WFJXTANAMJIBIO-UHFFFAOYSA-N CC(C)(C)OC(NC(C=CN1Cc(cc2)cc(-c3cccc(NO)c3)c2OC)=CC1=O)=O Chemical compound CC(C)(C)OC(NC(C=CN1Cc(cc2)cc(-c3cccc(NO)c3)c2OC)=CC1=O)=O WFJXTANAMJIBIO-UHFFFAOYSA-N 0.000 description 1
- HIUNFHGBLGBPNQ-UHFFFAOYSA-N CC(C)(c1ccc(Cc(cc2)cc(-c3cc(Cl)ccc3)c2OC(F)F)cn1)O Chemical compound CC(C)(c1ccc(Cc(cc2)cc(-c3cc(Cl)ccc3)c2OC(F)F)cn1)O HIUNFHGBLGBPNQ-UHFFFAOYSA-N 0.000 description 1
- CLUKOAZZAPBHEA-UHFFFAOYSA-N CC(C1c2cc(Cl)ccc2)=CC=C(Cc2ccc(CN)nc2)C1F Chemical compound CC(C1c2cc(Cl)ccc2)=CC=C(Cc2ccc(CN)nc2)C1F CLUKOAZZAPBHEA-UHFFFAOYSA-N 0.000 description 1
- XAMCEYGGKBHZJL-UHFFFAOYSA-N CC(Nc1ccc(Cc(c(F)c2-c3cc(C)ccc3)ccc2OC)cc1)=O Chemical compound CC(Nc1ccc(Cc(c(F)c2-c3cc(C)ccc3)ccc2OC)cc1)=O XAMCEYGGKBHZJL-UHFFFAOYSA-N 0.000 description 1
- PRPSGCMFDARUCS-UHFFFAOYSA-N CC(c(cc1)ccc1-[n]1nccc1)c(ccc(OC)c1-c2cc([N+]([O-])=O)ccc2)c1O Chemical compound CC(c(cc1)ccc1-[n]1nccc1)c(ccc(OC)c1-c2cc([N+]([O-])=O)ccc2)c1O PRPSGCMFDARUCS-UHFFFAOYSA-N 0.000 description 1
- FUENOUZNOITENB-UHFFFAOYSA-N CC(c(cc1)ccc1NC(N)=O)(c(ccc(OC)c1-c2cccc(Cl)c2)c1F)O Chemical compound CC(c(cc1)ccc1NC(N)=O)(c(ccc(OC)c1-c2cccc(Cl)c2)c1F)O FUENOUZNOITENB-UHFFFAOYSA-N 0.000 description 1
- HIKPVNLWNXBMHP-UHFFFAOYSA-N CC(c1cccc(-c(c(F)c(Cc(cc2)ccc2N)cc2)c2OC)c1)=O Chemical compound CC(c1cccc(-c(c(F)c(Cc(cc2)ccc2N)cc2)c2OC)c1)=O HIKPVNLWNXBMHP-UHFFFAOYSA-N 0.000 description 1
- WBARPUMSKMQFPD-UHFFFAOYSA-N CC(c1cccc(-c(c(F)c(Cc(cc2)ccc2NC(N)=O)cc2)c2OC)c1)=O Chemical compound CC(c1cccc(-c(c(F)c(Cc(cc2)ccc2NC(N)=O)cc2)c2OC)c1)=O WBARPUMSKMQFPD-UHFFFAOYSA-N 0.000 description 1
- WAEHCWXUVOGQNY-UHFFFAOYSA-N CC(c1cccc(-c(c(F)c(Cc2cnc(NC(NCCCl)=O)nc2)cc2)c2OC)c1)=O Chemical compound CC(c1cccc(-c(c(F)c(Cc2cnc(NC(NCCCl)=O)nc2)cc2)c2OC)c1)=O WAEHCWXUVOGQNY-UHFFFAOYSA-N 0.000 description 1
- WFWKDSNSQSFPLZ-UHFFFAOYSA-N CC(c1cccc(C(C2)C(OC)=CC=C2Nc(cc2)ccc2NC(N)=O)c1)=O Chemical compound CC(c1cccc(C(C2)C(OC)=CC=C2Nc(cc2)ccc2NC(N)=O)c1)=O WFWKDSNSQSFPLZ-UHFFFAOYSA-N 0.000 description 1
- FWDUXRFBKNOSQY-HWKANZROSA-N CC/C=C/c1cc(NO)ccc1 Chemical compound CC/C=C/c1cc(NO)ccc1 FWDUXRFBKNOSQY-HWKANZROSA-N 0.000 description 1
- NKHNHTGOKPLCFX-UHFFFAOYSA-N CC1(C)OB(C2C=CC(C#N)=NC2)OC1(C)C Chemical compound CC1(C)OB(C2C=CC(C#N)=NC2)OC1(C)C NKHNHTGOKPLCFX-UHFFFAOYSA-N 0.000 description 1
- PFBRKGDRUWEIFI-UHFFFAOYSA-N CC1(C)OB(c2cnc(CN)cc2)OC1(C)C Chemical compound CC1(C)OB(c2cnc(CN)cc2)OC1(C)C PFBRKGDRUWEIFI-UHFFFAOYSA-N 0.000 description 1
- MJLCNIISARLHBK-UHFFFAOYSA-N CN(C)CCOc1ncc(Cc(ccc(OC)c2-c3cc(Cl)ccc3)c2F)cc1 Chemical compound CN(C)CCOc1ncc(Cc(ccc(OC)c2-c3cc(Cl)ccc3)c2F)cc1 MJLCNIISARLHBK-UHFFFAOYSA-N 0.000 description 1
- TZIYXUUNTRDEDJ-UHFFFAOYSA-N CN(C)c(cc1)ccc1C(c(ccc(OC)c1-c2cc([N+]([O-])=O)ccc2)c1O)=O Chemical compound CN(C)c(cc1)ccc1C(c(ccc(OC)c1-c2cc([N+]([O-])=O)ccc2)c1O)=O TZIYXUUNTRDEDJ-UHFFFAOYSA-N 0.000 description 1
- VZIAHBSVTYFZEH-UHFFFAOYSA-N CN(C)c1ccc(Cc(ccc(OC)c2-c3cc([N+]([O-])=O)ccc3)c2O)cc1 Chemical compound CN(C)c1ccc(Cc(ccc(OC)c2-c3cc([N+]([O-])=O)ccc3)c2O)cc1 VZIAHBSVTYFZEH-UHFFFAOYSA-N 0.000 description 1
- MEQIELDIZQSRND-UHFFFAOYSA-N CN(CC(N)=O)c1ncc(Cc(cc2)cc(-c3cc(Cl)ccc3)c2OC(F)F)cc1 Chemical compound CN(CC(N)=O)c1ncc(Cc(cc2)cc(-c3cc(Cl)ccc3)c2OC(F)F)cc1 MEQIELDIZQSRND-UHFFFAOYSA-N 0.000 description 1
- ICFUQMDDFMCWGY-UHFFFAOYSA-N CN(CCN1c2ncc(Cc(ccc(OC)c3-c4cc(Cl)ccc4)c3F)cc2)C1=O Chemical compound CN(CCN1c2ncc(Cc(ccc(OC)c3-c4cc(Cl)ccc4)c3F)cc2)C1=O ICFUQMDDFMCWGY-UHFFFAOYSA-N 0.000 description 1
- FHHGYNMMPRBCQQ-UHFFFAOYSA-N CNC(NC1OCCC1)=O Chemical compound CNC(NC1OCCC1)=O FHHGYNMMPRBCQQ-UHFFFAOYSA-N 0.000 description 1
- BYHVZSNNPIQFMN-UHFFFAOYSA-N COC(OCc(c(F)c1-c2cc(Cl)ccc2)ccc1OC)=O Chemical compound COC(OCc(c(F)c1-c2cc(Cl)ccc2)ccc1OC)=O BYHVZSNNPIQFMN-UHFFFAOYSA-N 0.000 description 1
- CREKJQXDDXUEKP-UHFFFAOYSA-N COC(OCc(cc1)cc(-c2cc(Cl)ccc2)c1OC(F)F)=O Chemical compound COC(OCc(cc1)cc(-c2cc(Cl)ccc2)c1OC(F)F)=O CREKJQXDDXUEKP-UHFFFAOYSA-N 0.000 description 1
- ODAXNYMENLFYMY-UHFFFAOYSA-N COC(c1c(B(O)O)cccc1)=O Chemical compound COC(c1c(B(O)O)cccc1)=O ODAXNYMENLFYMY-UHFFFAOYSA-N 0.000 description 1
- ATVMOTGKXAFJNI-UHFFFAOYSA-N COC(c1c(Cc(cc2)cc(C(C=CC3)=CC3NO)c2OC)cccc1)=O Chemical compound COC(c1c(Cc(cc2)cc(C(C=CC3)=CC3NO)c2OC)cccc1)=O ATVMOTGKXAFJNI-UHFFFAOYSA-N 0.000 description 1
- DQHGUUNPLFSDQF-UHFFFAOYSA-N COc(cc1)c(-c2cc(Cl)ccc2)c(F)c1C(c(cc1)ccc1NC(N)=O)=O Chemical compound COc(cc1)c(-c2cc(Cl)ccc2)c(F)c1C(c(cc1)ccc1NC(N)=O)=O DQHGUUNPLFSDQF-UHFFFAOYSA-N 0.000 description 1
- OVUMZFYZMKGAAN-UHFFFAOYSA-N COc(ccc(CN(C(CCC1)=O)C1=O)c1)c1-c1cc(NO)ccc1 Chemical compound COc(ccc(CN(C(CCC1)=O)C1=O)c1)c1-c1cc(NO)ccc1 OVUMZFYZMKGAAN-UHFFFAOYSA-N 0.000 description 1
- HUTQCGIVXOCSSA-UHFFFAOYSA-N COc(ccc(CN(C(c1c2cncc1)=O)C2=O)c1)c1-c1cccc(NO)c1 Chemical compound COc(ccc(CN(C(c1c2cncc1)=O)C2=O)c1)c1-c1cccc(NO)c1 HUTQCGIVXOCSSA-UHFFFAOYSA-N 0.000 description 1
- PPCUFGZHXBJXGK-MRXNPFEDSA-N COc(ccc(CN(CC1)C[C@@H]1O)c1)c1-c1cc(NO)ccc1 Chemical compound COc(ccc(CN(CC1)C[C@@H]1O)c1)c1-c1cc(NO)ccc1 PPCUFGZHXBJXGK-MRXNPFEDSA-N 0.000 description 1
- ATWDFILRHANAMM-UHFFFAOYSA-N COc(ccc(CN1N=C(C=CC=C2)N2C1=O)c1)c1-c1cc(NO)ccc1 Chemical compound COc(ccc(CN1N=C(C=CC=C2)N2C1=O)c1)c1-c1cc(NO)ccc1 ATWDFILRHANAMM-UHFFFAOYSA-N 0.000 description 1
- ZHNQKTHBCUOEKV-UHFFFAOYSA-N COc(ccc(CSc(cc1)ccc1F)c1)c1-c1cccc([NH+]=[O-])c1 Chemical compound COc(ccc(CSc(cc1)ccc1F)c1)c1-c1cccc([NH+]=[O-])c1 ZHNQKTHBCUOEKV-UHFFFAOYSA-N 0.000 description 1
- LTVWGJHEHZFSMN-UHFFFAOYSA-N COc(ccc(CSc(cc1)ccc1F)c1)c1Br Chemical compound COc(ccc(CSc(cc1)ccc1F)c1)c1Br LTVWGJHEHZFSMN-UHFFFAOYSA-N 0.000 description 1
- JUMXVVXBWZXUOI-UHFFFAOYSA-N COc(ccc(C[N](CO)(cc1)cc1C(O)=O)c1)c1-c1cc(N)ccc1 Chemical compound COc(ccc(C[N](CO)(cc1)cc1C(O)=O)c1)c1-c1cc(N)ccc1 JUMXVVXBWZXUOI-UHFFFAOYSA-N 0.000 description 1
- GPMRWATVURGKMV-UHFFFAOYSA-N COc(ccc(C[n]1cncc1)c1)c1-c1cc2n[o]nc2cc1 Chemical compound COc(ccc(C[n]1cncc1)c1)c1-c1cc2n[o]nc2cc1 GPMRWATVURGKMV-UHFFFAOYSA-N 0.000 description 1
- YYAUYQQLYINRKN-UHFFFAOYSA-N COc1c(-c2cc(Cl)ccc2)c(F)c(CO)cc1 Chemical compound COc1c(-c2cc(Cl)ccc2)c(F)c(CO)cc1 YYAUYQQLYINRKN-UHFFFAOYSA-N 0.000 description 1
- GGSUPPYUHKTREB-UHFFFAOYSA-N COc1c(-c2cc(Cl)ccc2)c(F)c(C[n]2nc(C(F)(F)F)cc2-c2cccnc2)cc1 Chemical compound COc1c(-c2cc(Cl)ccc2)c(F)c(C[n]2nc(C(F)(F)F)cc2-c2cccnc2)cc1 GGSUPPYUHKTREB-UHFFFAOYSA-N 0.000 description 1
- AJWCMQQJSXCKCI-UHFFFAOYSA-N COc1c(-c2cc(Cl)ccc2)c(F)c(C[n]2ncc(-c3ccccn3)c2)cc1 Chemical compound COc1c(-c2cc(Cl)ccc2)c(F)c(C[n]2ncc(-c3ccccn3)c2)cc1 AJWCMQQJSXCKCI-UHFFFAOYSA-N 0.000 description 1
- XKADHMNGBWLMGY-UHFFFAOYSA-N COc1c(-c2cc(Cl)ccc2)c(F)c(Cc2cnc(N(C3)CC3O)nc2)cc1 Chemical compound COc1c(-c2cc(Cl)ccc2)c(F)c(Cc2cnc(N(C3)CC3O)nc2)cc1 XKADHMNGBWLMGY-UHFFFAOYSA-N 0.000 description 1
- ZJXSILWYTSIJKQ-UHFFFAOYSA-N COc1c(-c2cc(NO)ccc2)nc(C[Br]=C)cc1 Chemical compound COc1c(-c2cc(NO)ccc2)nc(C[Br]=C)cc1 ZJXSILWYTSIJKQ-UHFFFAOYSA-N 0.000 description 1
- XGLJSGIDGJOQOG-UHFFFAOYSA-N COc1c(-c2cc([N+]([O-])=O)ccc2)c(O)c(Cc(cc2)ccc2-[n]2nccc2)cc1 Chemical compound COc1c(-c2cc([N+]([O-])=O)ccc2)c(O)c(Cc(cc2)ccc2-[n]2nccc2)cc1 XGLJSGIDGJOQOG-UHFFFAOYSA-N 0.000 description 1
- IGRMOMGUKGJIKJ-UHFFFAOYSA-N COc1c(-c2cccc(Cl)c2)c(F)c(Cc(cc2)cnc2F)cc1 Chemical compound COc1c(-c2cccc(Cl)c2)c(F)c(Cc(cc2)cnc2F)cc1 IGRMOMGUKGJIKJ-UHFFFAOYSA-N 0.000 description 1
- QIXIQGVUILOKST-LBPRGKRZSA-N C[C@@H]1NC(CNC(Oc2ccccc2)=O)=CC=C1C Chemical compound C[C@@H]1NC(CNC(Oc2ccccc2)=O)=CC=C1C QIXIQGVUILOKST-LBPRGKRZSA-N 0.000 description 1
- UWYIICPSKBJXOP-UHFFFAOYSA-O C[N+](c1cc(Cc(ccc(OC)c2-c3cc(Cl)ccc3)c2F)cc(O)c1)=O Chemical compound C[N+](c1cc(Cc(ccc(OC)c2-c3cc(Cl)ccc3)c2F)cc(O)c1)=O UWYIICPSKBJXOP-UHFFFAOYSA-O 0.000 description 1
- GZHGCFWBBRYSHG-UHFFFAOYSA-N Cc(cc(C[n]1cncc1)cc1)c1OC Chemical compound Cc(cc(C[n]1cncc1)cc1)c1OC GZHGCFWBBRYSHG-UHFFFAOYSA-N 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N O=C(CC1)NC1=O Chemical compound O=C(CC1)NC1=O KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N O=C(CCC1)NC1=O Chemical compound O=C(CCC1)NC1=O KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 description 1
- SJSABZBUTDSWMJ-UHFFFAOYSA-N O=C(c1c2cncc1)NC2=O Chemical compound O=C(c1c2cncc1)NC2=O SJSABZBUTDSWMJ-UHFFFAOYSA-N 0.000 description 1
- LJRXNXBFJXXRNQ-UHFFFAOYSA-N O=C1N(C=CC=C2)C2=NN1 Chemical compound O=C1N(C=CC=C2)C2=NN1 LJRXNXBFJXXRNQ-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N O=C1NCCC1 Chemical compound O=C1NCCC1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- NFDLAXGJTCSMIZ-UHFFFAOYSA-N OC(CC=C(CC(CC1)CNC1F)C1)C1C(CC=C1)C=C1Cl Chemical compound OC(CC=C(CC(CC1)CNC1F)C1)C1C(CC=C1)C=C1Cl NFDLAXGJTCSMIZ-UHFFFAOYSA-N 0.000 description 1
- JHHZLHWJQPUNKB-SCSAIBSYSA-N O[C@H]1CNCC1 Chemical compound O[C@H]1CNCC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/58—Y being a hetero atom
- C07C275/62—Y being a nitrogen atom, e.g. biuret
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
- C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98955107P | 2007-11-21 | 2007-11-21 | |
PCT/US2008/084193 WO2009067600A2 (en) | 2007-11-21 | 2008-11-20 | Biaryl pde4 inhibitors for treating inflammation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014046962A Division JP2014185149A (ja) | 2007-11-21 | 2014-03-10 | 炎症を治療するためのビアリールpde4阻害薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011505341A true JP2011505341A (ja) | 2011-02-24 |
JP2011505341A5 JP2011505341A5 (zh) | 2013-03-14 |
Family
ID=41650335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010535064A Pending JP2011505341A (ja) | 2007-11-21 | 2008-11-20 | 炎症性、心血管およびcns障害を治療するビアリールpde4抑制剤 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2222638A2 (zh) |
JP (1) | JP2011505341A (zh) |
CN (1) | CN102089279A (zh) |
AU (1) | AU2008326381B2 (zh) |
CA (1) | CA2722582A1 (zh) |
WO (1) | WO2009067600A2 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013532734A (ja) * | 2010-08-04 | 2013-08-19 | ユニバーシティ オブ バージニア パテント ファウンデーション | 炎症性疾患を治療するための組成物及び方法 |
JP2016512259A (ja) * | 2013-03-14 | 2016-04-25 | ダート・ニューロサイエンス・(ケイマン)・リミテッド | Pde4阻害剤としての置換ピリジン及びピラジン化合物 |
JP2019522005A (ja) * | 2016-07-05 | 2019-08-08 | グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド | 芳香族アセチレンまたは芳香族エチレン系化合物、その中間体、製造方法、薬物組成物および使用 |
US11384048B2 (en) | 2017-12-29 | 2022-07-12 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2462240T3 (es) | 2006-02-28 | 2014-05-22 | Dart Neuroscience (Cayman) Ltd | Piperazinas terapéuticas como inhibidores de PDE4 |
EP2628727A3 (en) | 2007-11-21 | 2013-12-25 | Decode Genetics EHF | Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders |
WO2010059838A2 (en) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects |
WO2012003405A1 (en) | 2010-06-30 | 2012-01-05 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
NZ609955A (en) | 2010-11-09 | 2015-05-29 | Ironwood Pharmaceuticals Inc | Sgc stimulators |
US9540361B2 (en) * | 2010-12-24 | 2017-01-10 | Merck Sharp & Dohme B.V. | N-substituted azetidine derivatives |
CN102617457A (zh) * | 2011-01-28 | 2012-08-01 | 天津药物研究院 | 一种制备罗氟司特的新方法 |
CN103012255B (zh) * | 2011-09-21 | 2014-06-11 | 天津康鸿医药科技发展有限公司 | 罗氟司特晶型化合物、其制备方法、组合物及应用 |
CN102603676B (zh) * | 2012-02-20 | 2014-02-12 | 徐江平 | 一种能避免呕吐反应的磷酸二酯酶4抑制剂 |
US8865723B2 (en) | 2012-10-25 | 2014-10-21 | Tetra Discovery Partners Llc | Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury |
CN104884452A (zh) | 2012-11-20 | 2015-09-02 | 沃泰克斯药物股份有限公司 | 用作吲哚胺2,3-二氧化酶的抑制剂的化合物 |
CN103012408B (zh) * | 2012-11-28 | 2015-02-04 | 中国科学院广州生物医药与健康研究院 | 依匹斯汀的合成方法 |
CN106458896A (zh) | 2014-03-14 | 2017-02-22 | 沃克哈特有限公司 | (2s,5r)‑6‑(苄氧基)‑7‑氧代‑1,6‑二氮杂二环[3.2.1]辛烷‑2‑羧酸钠的制备方法 |
PL3209655T3 (pl) | 2014-10-24 | 2020-12-28 | Landos Biopharma, Inc. | Leczenie oparte na białku 2 podobnym do syntetazy lantioniny C |
EP3165224A1 (en) | 2015-11-09 | 2017-05-10 | Albert-Ludwigs-Universität Freiburg | Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
EA202091325A1 (ru) | 2017-11-30 | 2020-08-28 | Лэндос Байофарма, Инк. | Способы лечения с помощью лигандов лантионин c-подобного белка 2 и подготовленных с их помощью клеток |
CN110041253B (zh) * | 2018-01-17 | 2022-03-29 | 上海翰森生物医药科技有限公司 | 吡啶类n-氧化衍生物及其制备方法和应用 |
JP2022531129A (ja) | 2019-04-23 | 2022-07-06 | テトラ ディスカバリー パートナーズ インコーポレイテッド | Pde4d阻害剤としての3-ヒドロキシ-2-フェニル-6-(ピラゾール-4-イルメチル)ピリジン誘導体 |
JP7430852B2 (ja) | 2019-12-20 | 2024-02-14 | エヌイミューン バイオファーマ インコーポレイテッド | ランチオニンc様タンパク質2リガンド、それを用いて調製される細胞、およびそれを使用する療法 |
US20240101552A1 (en) | 2020-09-18 | 2024-03-28 | Shanghai Pharmaceuticals Holding Co., Ltd. | Carbonyl heterocyclic compound and application thereof |
CN112374984A (zh) * | 2020-11-06 | 2021-02-19 | 苏州求索生物科技有限公司 | 一种2-溴-4-羟基苯甲醚的制备工艺 |
KR102514860B1 (ko) * | 2020-12-01 | 2023-03-29 | 한국과학기술연구원 | 5-ht7 세로토닌 수용체 활성 저해용 바이페닐 피롤리딘 및 바이페닐 다이하이드로이미다졸 유도체 및 이를 유효성분으로 포함하는 약학 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003967A1 (en) * | 1995-07-22 | 1997-02-06 | Rhone-Poulenc Rorer Limited | Substituted aromatic compounds and their pharmaceutical use |
JPH10114724A (ja) * | 1996-10-04 | 1998-05-06 | Adir | 新規置換ビフェニル又はフェニルピリジン化合物、それらの製造方法及びそれらを含む医薬組成物 |
JP2011504505A (ja) * | 2007-11-21 | 2011-02-10 | デコード ジェネティクス イーエイチエフ | 肺および心血管障害を治療するためのビアリールpde4抑制剤 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3778430D1 (en) * | 1986-06-20 | 1992-05-27 | Idemitsu Kosan Co | Polycarbonate. |
GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
CA2144669A1 (en) * | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
EP0793662A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
US5594141A (en) * | 1994-11-23 | 1997-01-14 | Neurogen Corporation | Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands |
GB9604926D0 (en) * | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
WO1999031062A1 (fr) * | 1997-12-17 | 1999-06-24 | Shionogi & Co., Ltd. | Nouveaux composes de pyridine |
AU3363599A (en) * | 1998-03-26 | 1999-10-18 | Max-Planck Institut Fur Biochemie | Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
EP1112262B1 (en) * | 1998-09-09 | 2004-08-04 | Inflazyme Pharmaceuticals Ltd. | Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
EP1227086B1 (en) * | 1999-10-22 | 2006-03-29 | Takeda Pharmaceutical Company Limited | 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
AU2002252227A1 (en) * | 2001-03-07 | 2002-09-24 | Maxia Pharmaceuticals, Inc. | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
WO2003094845A2 (en) * | 2002-05-08 | 2003-11-20 | Bristol-Myers Squibb Company | Pyridine-based thyroid receptor ligands |
AU2003277576A1 (en) * | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
CN101468965A (zh) * | 2003-03-24 | 2009-07-01 | 默克公司 | 联芳基取代的6元杂环钠通道阻滞剂 |
JP2006522130A (ja) * | 2003-04-03 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | ナトリウムチャンネル遮断薬としてのビアリール置換ピラゾール |
US7557143B2 (en) * | 2003-04-18 | 2009-07-07 | Bristol-Myers Squibb Company | Thyroid receptor ligands |
WO2005030206A1 (en) * | 2003-09-24 | 2005-04-07 | Imclone Systems Incorporated | Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
US20090074890A1 (en) * | 2003-11-10 | 2009-03-19 | Park Min K | Substituted Triazoles as Sodium Channel Blockers |
WO2005051298A2 (en) * | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
BRPI0418148A (pt) * | 2003-12-25 | 2007-04-17 | Takeda Pharmaceutical | composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto |
AR053784A1 (es) * | 2004-11-23 | 2007-05-23 | Pfizer Prod Inc | Compuestos y derivados tetrazolicos de dibencil amina. composiciones farmaceuticas. |
CA2590246C (en) * | 2004-12-23 | 2015-07-14 | Galderma Research & Development | Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
KR20070107022A (ko) * | 2005-01-07 | 2007-11-06 | 신타 파마슈티칼스 코프. | 염증 및 면역 관련 용도를 위한 화합물 |
HUE032640T2 (en) * | 2005-11-08 | 2017-10-30 | Vertex Pharma | Heterocyclic modulator of ATP-binding cassette transcripts |
NZ569327A (en) * | 2005-12-28 | 2011-09-30 | Vertex Pharma | 1-(benzo [d] [1,3] dioxol-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis |
US7915271B2 (en) * | 2005-12-30 | 2011-03-29 | Merck Sharp & Dohme Corp. | 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors |
UA93548C2 (uk) * | 2006-05-05 | 2011-02-25 | Айерем Елелсі | Сполуки та композиції як модулятори хеджхогівського сигнального шляху |
EP2036887A1 (en) * | 2006-06-28 | 2009-03-18 | Sanwa Kagaku Kenkyusho Co., Ltd | Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
CN103980151A (zh) * | 2006-08-09 | 2014-08-13 | 史密丝克莱恩比彻姆公司 | 作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物 |
JP2010522214A (ja) * | 2007-03-21 | 2010-07-01 | アルミラル, エセ.アー. | アデノシンレセプターアンタゴニストとしての置換ピリミジン |
FR2932180B1 (fr) * | 2008-06-04 | 2012-08-10 | Centre Nat Rech Scient | Dihydro iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de la polymerisation de la tubuline |
-
2008
- 2008-11-20 AU AU2008326381A patent/AU2008326381B2/en not_active Expired - Fee Related
- 2008-11-20 EP EP08851045A patent/EP2222638A2/en not_active Withdrawn
- 2008-11-20 CA CA2722582A patent/CA2722582A1/en not_active Abandoned
- 2008-11-20 JP JP2010535064A patent/JP2011505341A/ja active Pending
- 2008-11-20 CN CN2008801251758A patent/CN102089279A/zh active Pending
- 2008-11-20 WO PCT/US2008/084193 patent/WO2009067600A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003967A1 (en) * | 1995-07-22 | 1997-02-06 | Rhone-Poulenc Rorer Limited | Substituted aromatic compounds and their pharmaceutical use |
JPH10114724A (ja) * | 1996-10-04 | 1998-05-06 | Adir | 新規置換ビフェニル又はフェニルピリジン化合物、それらの製造方法及びそれらを含む医薬組成物 |
JP2011504505A (ja) * | 2007-11-21 | 2011-02-10 | デコード ジェネティクス イーエイチエフ | 肺および心血管障害を治療するためのビアリールpde4抑制剤 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013532734A (ja) * | 2010-08-04 | 2013-08-19 | ユニバーシティ オブ バージニア パテント ファウンデーション | 炎症性疾患を治療するための組成物及び方法 |
US9617197B2 (en) | 2010-08-04 | 2017-04-11 | University Of Virginia Patent Foundation | Compositions and methods for treating inflammatory diseases |
JP2016512259A (ja) * | 2013-03-14 | 2016-04-25 | ダート・ニューロサイエンス・(ケイマン)・リミテッド | Pde4阻害剤としての置換ピリジン及びピラジン化合物 |
JP2018062529A (ja) * | 2013-03-14 | 2018-04-19 | ダート・ニューロサイエンス・(ケイマン)・リミテッド | Pde4阻害剤としての置換ピリジン及びピラジン化合物 |
JP2019522005A (ja) * | 2016-07-05 | 2019-08-08 | グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド | 芳香族アセチレンまたは芳香族エチレン系化合物、その中間体、製造方法、薬物組成物および使用 |
US11078192B2 (en) | 2016-07-05 | 2021-08-03 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof |
JP6994496B2 (ja) | 2016-07-05 | 2022-01-14 | グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド | 芳香族アセチレンまたは芳香族エチレン系化合物、その中間体、製造方法、薬物組成物および使用 |
US11384048B2 (en) | 2017-12-29 | 2022-07-12 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application |
Also Published As
Publication number | Publication date |
---|---|
AU2008326381A1 (en) | 2009-05-28 |
WO2009067600A2 (en) | 2009-05-28 |
EP2222638A2 (en) | 2010-09-01 |
CN102089279A (zh) | 2011-06-08 |
AU2008326381B2 (en) | 2014-10-23 |
CA2722582A1 (en) | 2009-05-28 |
WO2009067600A3 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8791267B2 (en) | Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders | |
JP2011505341A (ja) | 炎症性、心血管およびcns障害を治療するビアリールpde4抑制剤 | |
TWI504604B (zh) | 雜環化合物及其用途 | |
KR100235277B1 (ko) | 피라졸로- 및 피롤로-피리딘 | |
JP6063870B2 (ja) | RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療 | |
TWI721335B (zh) | 鹵代烯丙基胺類ssao/vap-1抑制劑及其用途 | |
CA2901502A1 (en) | Amide compounds for the treatment of hiv | |
HRP20000253A2 (en) | Indazole bioisostere replacement of catechol in therapeutically active compounds | |
WO2010059838A2 (en) | Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects | |
WO2010059836A1 (en) | Substituted aza-bridged bicyclics for cardiovascular and cns disease | |
CN102459202A (zh) | 作为脂肪酸酰胺水解酶的抑制剂的异噁唑啉 | |
US20160257645A1 (en) | Inhibitors of human immunodeficiency virus replication | |
JP2021105002A (ja) | イミダゾピリダジン化合物 | |
EP3164399A1 (en) | Thiophen-2-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators | |
JP2011504183A (ja) | 炎症、心血管およびcns障害を治療する置換されたベンゾ・アゾールpde4抑制剤 | |
KR20220141331A (ko) | P2x3 조정제 | |
US20230102554A1 (en) | Heterocyclic kinase inhibitors and products and uses thereof | |
KR101820541B1 (ko) | 8-옥소디히드로퓨린 유도체 | |
TWI228990B (en) | Non-nucleoside reverse transcriptase inhibitors | |
JP4762917B2 (ja) | 非ヌクレオシド逆転写酵素インヒビター | |
WO2009067597A1 (en) | 4- (or 5-) substituted catechol derivatives | |
TW202134213A (zh) | 具有水解磷脂酸受體作動活性之化合物及其醫藥用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A524 | Written submission of copy of amendment under section 19 (pct) |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20101207 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111118 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130116 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130905 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130910 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131203 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131210 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140507 |